|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/10 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 3464265 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17728614.3 |
| Date of filing the European patent application | 2017-06-01 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-13 |
| (46) | Date of publication of the claims translation | 2022-11-10 |
| (86) | Number | PCT/GB2017/051579 |
| Date | 2017-06-01 |
| (87) | Number | WO 2017/208005 |
| Date | 2017-12-07 |
| (30) | Number | Date | Country code |
| 201609607 | 2016-06-01 | GB | |
| 201662344059 P | 2016-06-01 | US |
| (72) |
BEATON, Haydn , GB
CROWE, David Malcolm , GB
EDWARDS, Hannah Joy , GB
GRIFFITHS-HAYNES, Nicholas James , GB
|
| (73) |
Kalvista Pharmaceuticals Limited ,
Porton Science Park
Bybrook Road, Porton Down
Wiltshire SP4 0BF,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | N-[(3-fluor-4-metoksipiridin-2-il)metil]-3-(metoksimetil)-1-({4-[2-oksopiridin-1- il)metil]fenil}metil)pirazol-4-karboksamido polimorfai kaip kalikreino inhibitoriai |
| POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AS KALLIKREIN INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 9 | 208.00 EUR |
| 2026-06-01 |